CDW
CDW Corporation
CDW's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CDW overall, supported by stronger modeled upside and stronger fundamentals.
CDW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
CDW's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CDW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $173 | — |
| Cheap | 19x | $166 | -4.2% |
| Current | 20x | $173 | — |
| Fair | 24x | $205 | +19% |
| Expensive | 28x | $243 | +41% |
Historical ranges are pointers, not guarantees.
CDW's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CDW in the historical PE scenario, which offers more potential upside but is not a forecast.
CDW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
CDW has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CDW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.14 | +42% |
| Q3 2026 | $8.56 | +8.1% |
| Q2 2026 | $8.31 | +3.2% |
| Q1 2026 | $8.21 | +1.7% |
| Q4 2025 | $8.08 | +1.4% |
| Q3 2025 | $7.92 | -3.2% |
| Q2 2025 | $8.05 | -1.3% |
| Q1 2025 | $8.07 | +0.7% |
| Q4 2024 | $7.97 | -1.6% |
CDW earned $8.56 per share over the past year, up 8.1% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CDW on earnings, with more consistent year-over-year improvement.
CDW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.8B | +18% |
| Q2 2026 | $6.6B | +10% |
| Q1 2026 | $5.7B | +9.2% |
| Q4 2025 | $5.5B | +6.3% |
| Q3 2025 | $5.7B | +4% |
| Q2 2025 | $6B | +10% |
| Q1 2025 | $5.2B | +6.7% |
| Q4 2024 | $5.2B | +3.3% |
CDW's revenue has grown year over year for eight quarters in a row: $6.8B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.3% | -0.5 points |
| Q2 2026 | 6.5% | -0.5 points |
| Q1 2026 | 6.6% | -0.3 points |
| Q4 2025 | 7.8% | -0.1 points |
| Q3 2025 | 7.7% | -1 points |
| Q2 2025 | 7% | -1 points |
| Q1 2025 | 7% | +0.2 points |
| Q4 2024 | 7.9% | -0.8 points |
CDW's operating margin was 7.3% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CDW on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CDW on profitability, with a higher operating margin.
CDW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $372M | +25% |
| Q2 2026 | -$82.6M | -162% |
| Q1 2026 | $248.4M | -4.6% |
| Q4 2025 | $395.9M | +25% |
| Q3 2025 | $298.5M | -3.2% |
| Q2 2025 | $133.4M | +12% |
| Q1 2025 | $260.3M | -37% |
| Q4 2024 | $316.7M | -37% |
CDW still generates free cash flow, though less than at its 2020 peak: $934M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CDW on cash flow, with more consistent year-over-year improvement.
CDW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -1.7M shares |
| 1 year | -4.6% | -6.1M shares |
| 3 years | -7.5% | -10.2M shares |
| 5 years | -9.8% | -13.7M shares |
| Available history | -15% | -22.1M shares |
CDW has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $108M |
| Q2 2026 | $343.7M |
| Q1 2026 | $201M |
| Q4 2025 | $153M |
| Q3 2025 | $149.9M |
| Q2 2025 | $150M |
| Q1 2025 | $200.1M |
| Q4 2024 | $146M |
CDW spent $806M buying back its own shares over the past year, up 25% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CDW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.7x | Moderate |
| Q4 2024 | 2.8x | Moderate |
CDW's net debt is about 2.8 years of its operating earnings (EBITDA), about the same as a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over CDW on leverage, with a lower net debt burden relative to earnings.
CDW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.9 | Neutral |
| Stochastic | 81.9 | Overbought |
CDW's weekly RSI is 64 (neutral) and its Stochastic is 82 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CDW PE vs Technology Sector
| Metric | CDW | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 28x | 28% below |
| PE % | 19 | 35 | 16 pts below |
CDW has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CDW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $151.3 | 14% above |
| 20 week MA | $145.8 | 19% above |
| 50 week MA | $135.1 | 28% above |
| 100 week MA | $152.1 | 14% above |
| 200 week MA | $180.9 | 4.5% below |
CDW has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CDW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $144.0 | $129.2 | -10% |
| 2021 | $129.2 | $202.8 | +57% |
| 2022 | $202.8 | $178.1 | -12% |
| 2023 | $178.1 | $227.3 | +28% |
| 2024 | $227.3 | $175.8 | -23% |
| 2025 | $175.8 | $139.7 | -21% |
| 2026 YTD | $139.7 | $172.8 | +24% |
CDW has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.